Health ❯Healthcare

Clinical Research

Clinical Trials Patient Outcomes Drug Trials Drug Development Study Findings Drug Efficacy Epidemiology Drug Studies Data Analysis Phase 3 Trials

High Warfarin Levels Pose No Extra Brain Bleed Risk in Elderly Fall Patients

The findings suggest that inadequate INR control drives bleeding risk more than elevated warfarin levels in older fall patients.

DynaTag Maps Transcription Factor–DNA Interactions at Single-Cell Resolution and Uncovers Chemotherapy Resistance Dynamics

Glipizide Linked to 13% Higher Cardiovascular Risk Than DPP-4 Inhibitors

EMA Recommends Restricted Approval for Eli Lilly’s Alzheimer’s Drug Kisunla

EMA Committee Recommends EU Approval for First Oral Postpartum Depression Treatment

Fracture Risk Surges After Stopping Menopausal Hormone Therapy, Study Finds

Phase 3 Trial Validates Low-Dose Olanzapine for Chemo-Induced Nausea Without Heavy Sedation

Meta-Analysis Finds Predictable Weight Rebound After Stopping Anti-Obesity Drugs

GLP-1 Agonists Cut Dementia and Mortality Risk Versus Metformin in Type 2 Diabetes

Atrial Fibrillation at Time of Mitral Edge-to-Edge Repair Doubles Risk of Death or Rehospitalization

One-Third of Common Non-Antibiotics Undermine Gut Defenses, Fueling Salmonella Growth

One in Three Infants Received Preventive RSV Antibody in First Season, Study Finds

Independent Cohort Validates SIRPA Genotyping to Predict Kidney Transplant Rejection

WHO Recommends Six-Monthly Lenacapavir Injection for HIV Prevention

GLP-1 Weight-Loss Drugs Linked to Testosterone Normalization in Men

Hundreds of Non-Amyloid Proteins Tied to Age-Related Cognitive Decline

Guidelines Shift to Universal Hepatitis C Screening in Emergency Departments After Trial Shows 34% Boost in Case Detection

High-Dose Steroids Undermine Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Meta-Analysis Reveals Opposing Breast Cancer Risks of Hormone Replacement Therapy in Women Under 55

First-Trimester Gut Microbiome Signatures Predict Gestational Diabetes